DBV Technologies elects George Horner as non-executive Chairman of the Board of Directors to advance the clinical development of VIASKIN[R] Peanut, the world's first epicutaneous skin patch for desensitization of peanut allergy.
Business Wire › January 18, 2011
Linked as: